| RS121908830 |
TMEM127
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma, susceptibility to |
| RS121908831 |
TMEM127
|
Health Risk |
Likely pathogenic |
Pheochromocytoma, Pheochromocytoma |
| RS121908832 |
PNPLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS121908833 |
YARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease dominant intermediate C, Charcot-Marie-Tooth disease |
| RS121908834 |
YARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease dominant intermediate C, Charcot-Marie-Tooth disease |
| RS121908835 |
TP63
|
Health Risk |
Pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS121908836 |
TP63
|
Health Risk |
Pathogenic/Likely pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS121908837 |
TP63
|
Health Risk |
Pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS121908838 |
TP63
|
Health Risk |
Pathogenic |
Split hand-foot malformation 4, Split hand-foot malformation 4 |
| RS121908839 |
TP63
|
Health Risk |
Pathogenic |
Split hand-foot malformation 4, TP63-Related Spectrum Disorders |
| RS121908840 |
TP63
|
Health Risk |
Pathogenic/Likely pathogenic |
Rapp-Hodgkin syndrome, Ectrodactyly |
| RS121908841 |
TP63
|
Health Risk |
Pathogenic/Likely pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS121908842 |
TP63
|
Health Risk |
Pathogenic |
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome, Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome |
| RS121908843 |
TP63
|
Health Risk |
Likely pathogenic |
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome, TP63-Related Spectrum Disorders |
| RS121908844 |
TP63
|
Health Risk |
Pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS121908845 |
TP63
|
Health Risk |
Pathogenic |
Rapp-Hodgkin syndrome, Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome |
| RS121908846 |
TP63
|
Health Risk |
Pathogenic |
Rapp-Hodgkin syndrome, Rapp-Hodgkin syndrome |
| RS121908849 |
TP63
|
Health Risk |
Likely pathogenic |
ADULT syndrome, Ectrodactyly |
| RS121908853 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS121908854 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, CILIARY DYSKINESIA |
| RS121908855 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS121908856 |
SLC4A4
|
Health Risk |
Pathogenic |
Autosomal recessive proximal renal tubular acidosis, Autosomal recessive proximal renal tubular acidosis |
| RS121908857 |
SLC4A4
|
Health Risk |
Pathogenic |
Autosomal recessive proximal renal tubular acidosis, Autosomal recessive proximal renal tubular acidosis |
| RS121908858 |
SLC4A4
|
Health Risk |
Pathogenic |
Autosomal recessive proximal renal tubular acidosis, Autosomal recessive proximal renal tubular acidosis |
| RS121908859 |
TSHR
|
Health Risk |
Pathogenic |
Thyroid adenoma, hyperfunctioning |
| RS121908860 |
TSHR
|
Health Risk |
Pathogenic |
Thyroid adenoma, hyperfunctioning |
| RS121908861 |
TSHR
|
Health Risk |
Likely pathogenic |
Thyroid adenoma, hyperfunctioning |
| RS121908862 |
TSHR
|
Health Risk |
Pathogenic |
Hypothyroidism due to TSH receptor mutations, Hypothyroidism due to TSH receptor mutations |
| RS121908863 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism due to TSH receptor mutations, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908864 |
TSHR
|
Health Risk |
Likely pathogenic |
Familial hyperthyroidism due to mutations in TSH receptor, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908865 |
TSHR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypothyroidism due to TSH receptor mutations, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908866 |
TSHR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypothyroidism due to TSH receptor mutations, Inborn genetic diseases |
| RS121908867 |
TSHR
|
Health Risk |
Pathogenic |
Hypothyroidism due to TSH receptor mutations, Hypothyroidism due to TSH receptor mutations |
| RS121908869 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism due to TSH receptor mutations, Epilepsy |
| RS121908870 |
TSHR
|
Health Risk |
Pathogenic |
Hypothyroidism due to TSH receptor mutations, Hypothyroidism due to TSH receptor mutations |
| RS121908871 |
TSHR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypothyroidism due to TSH receptor mutations, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908872 |
TSHR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypothyroidism due to TSH receptor mutations, Inborn genetic diseases |
| RS121908873 |
TSHR
|
Health Risk |
Pathogenic |
Thyroid adenoma, hyperfunctioning |
| RS121908874 |
TSHR
|
Health Risk |
Pathogenic |
Familial hyperthyroidism due to mutations in TSH receptor, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908875 |
TSHR
|
Health Risk |
Pathogenic |
Familial hyperthyroidism due to mutations in TSH receptor, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908876 |
TSHR
|
Health Risk |
Likely pathogenic |
Familial hyperthyroidism due to mutations in TSH receptor, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908877 |
TSHR
|
Health Risk |
Pathogenic |
Familial hyperthyroidism due to mutations in TSH receptor, Thyroid adenoma |
| RS121908879 |
TSHR
|
Health Risk |
Pathogenic |
Familial gestational hyperthyroidism, Familial gestational hyperthyroidism |
| RS121908880 |
TSHR
|
Health Risk |
Pathogenic |
Familial hyperthyroidism due to mutations in TSH receptor, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908881 |
TSHR
|
Health Risk |
Likely pathogenic |
Hypothyroidism due to TSH receptor mutations, Hypothyroidism due to TSH receptor mutations |
| RS121908882 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism due to TSH receptor mutations, Hypothyroidism due to TSH receptor mutations |
| RS121908883 |
TSHR
|
Health Risk |
Pathogenic |
Familial hyperthyroidism due to mutations in TSH receptor, Familial hyperthyroidism due to mutations in TSH receptor |
| RS121908884 |
TSHR
|
Health Risk |
Pathogenic |
Hypothyroidism due to TSH receptor mutations, Hypothyroidism due to TSH receptor mutations |
| RS121908885 |
TSHR
|
Health Risk |
Pathogenic |
Hypothyroidism due to TSH receptor mutations, Hypothyroidism due to TSH receptor mutations |
| RS121908886 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, SLC22A5-related disorder |
| RS121908887 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS121908888 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS121908889 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Ovarian serous cystadenocarcinoma |
| RS121908890 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS121908891 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS121908892 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS121908893 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS121908894 |
FLNB
|
Health Risk |
Pathogenic |
Atelosteogenesis type I, Atelosteogenesis type I |
| RS121908895 |
FLNB
|
Health Risk |
Pathogenic |
Atelosteogenesis type I, Atelosteogenesis type III |
| RS121908896 |
FLNB
|
Health Risk |
Pathogenic |
Boomerang dysplasia, Boomerang dysplasia |
| RS121908897 |
FLNB
|
Health Risk |
Pathogenic |
Spondylocarpotarsal synostosis syndrome, Spondylocarpotarsal synostosis syndrome |
| RS121908898 |
FLNB
|
Health Risk |
Pathogenic |
Spondylocarpotarsal synostosis syndrome, Spondylocarpotarsal synostosis syndrome |
| RS121908900 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS121908901 |
CCN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive pseudorheumatoid dysplasia, See cases |
| RS121908902 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS121908903 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS121908904 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS121908905 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS121908906 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS121908907 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS121908908 |
SCN9A
|
Health Risk |
Pathogenic |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS121908909 |
SCN9A
|
Health Risk |
Pathogenic |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS121908910 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Paroxysmal extreme pain disorder, Generalized epilepsy with febrile seizures plus |
| RS121908911 |
SCN9A
|
Health Risk |
Pathogenic |
Paroxysmal extreme pain disorder, Paroxysmal extreme pain disorder |
| RS121908912 |
SCN9A
|
Health Risk |
Pathogenic |
Paroxysmal extreme pain disorder, Paroxysmal extreme pain disorder |
| RS121908913 |
SCN9A
|
Health Risk |
Likely pathogenic |
Paroxysmal extreme pain disorder, Generalized epilepsy with febrile seizures plus |
| RS121908914 |
SCN9A
|
Health Risk |
Likely pathogenic |
Paroxysmal extreme pain disorder, Neuropathy |
| RS121908915 |
SCN9A
|
Health Risk |
Pathogenic |
Paroxysmal extreme pain disorder, Generalized epilepsy with febrile seizures plus |
| RS121908916 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS121908917 |
SCN9A
|
Health Risk |
Pathogenic |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS121908918 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS121908922 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS121908923 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Slow-Channel Congenital Myasthenia Syndrome |
| RS121908924 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Synaptic congenital myasthenic syndromes |
| RS121908925 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS121908926 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS121908927 |
COCH
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 9, Autosomal dominant nonsyndromic hearing loss 9 |
| RS121908928 |
COCH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 9, Autosomal dominant nonsyndromic hearing loss 9 |
| RS121908929 |
COCH
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 9, Hereditary hearing loss and deafness |
| RS121908930 |
COCH
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 9, Autosomal dominant nonsyndromic hearing loss 9 |
| RS121908932 |
COCH
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 9, Rare genetic deafness |
| RS121908934 |
COCH
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 9, Autosomal dominant nonsyndromic hearing loss 9 |
| RS121908935 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS121908936 |
LCT
|
Health Risk |
Pathogenic |
Congenital lactase deficiency, Congenital lactase deficiency |
| RS121908937 |
LCT
|
Health Risk |
Pathogenic |
Congenital lactase deficiency, Congenital lactase deficiency |
| RS121908938 |
BFSP2
|
Health Risk |
Pathogenic |
Cataract 12 multiple types, BFSP2-related disorder |
| RS121908939 |
DNMT3B
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Immunodeficiency-centromeric instability-facial anomalies syndrome 1 |
| RS121908940 |
DNMT3B
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Centromeric instability of chromosomes 1 |
| RS121908941 |
DNMT3B
|
Health Risk |
Pathogenic/Likely pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS121908942 |
DNMT3B
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Immunodeficiency-centromeric instability-facial anomalies syndrome 1 |